The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease

The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease

The assessment of cancer patient care during the COVID-19 pandemic has been mainly reported from a physician’s perspective. Patients with rare tumor entities such as neuroendocrine tumors (NET), which require a complex and specialized care infrastructure, were highly affected by the COVID-19 crisis....

Full description

Bibliographic Details
Main Authors: Sebastian Krug, Maryam Khosravian, Julia Weissbach, Katharina George, Marko Damm, Jakob Garbe, Jens Walldorf, Philipp A. Reuken, Tania Amin, Alexander Siebenhüner, Jonas Rosendahl, Thomas M. Gress, Patrick Michl, Jörg Schrader, Anja Rinke
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
NET
neuroendocrine
COVID-19
SARS-CoV-2
survey
vaccination
Online Access:https://www.mdpi.com/2072-6694/14/3/613

Internet

https://www.mdpi.com/2072-6694/14/3/613

Similar Items